By attending this webinar,
you will receive 7 
from
Message from the 
"For information on how this activity fits in the Royal College Maintenance of Certification (MOC) Program, please visit the Royal College’s website. For more personalized support, please contact the Royal College Services Centre (1-800-461-9598) or your local CPD Educator."
Learning Objectives
- Explain and interpret the use of medicinal and recreational cannabis in Canada.
- Describe how cannabis includes THC and CBD, two chemicals with distinct pharmacological properties.
- Critique the evidence for the use of cannabis for the treatment of psychiatric disorders.
- Based on scientific evidence, appraise the risks THC poses for the developing brain.
- Appraise the evidence concerning the impact of THC on the development of psychiatric disorders, including schizophrenia.
- Review the evidence for the pharmacologically distinct psychedelics used in the treatment of psychiatric disorders.
Speaker
Dr. Diane McIntosh
BSc Pharmacy, MD, FRCPC Clinical Assistant Professor, University of British Columbia
Dr. McIntosh obtained an undergraduate degree in pharmacy before completing her medical school training, 2-years of a pediatric residency and then an adult psychiatry residency. She is a clinical assistant professor at the University of British Columbia and has a community psychiatry practice.
Dr. McIntosh is extensively involved in providing continuing medical education programs to colleagues nationally and internationally, with a focus on rational pharmacology and the neurobiology of mood and anxiety disorders and ADHD. Every year, she delivers more than 200 lectures, always coming back to an essential, central theme: we must strive to improve the quality of care and the treatment options available for people diagnosed with a mental illness.
Dr. McIntosh is the co-founder of SwitchRx, the online psychotropic switching tool for prescribers and pharmacists. She has her own continuing medical education program, PsychedUp, which was developed to encourage the appropriate, confident, rational prescribing of psychiatric medications. She has published blogs in Psychology Today and the Huffington Post and Op-Eds for newspapers focusing on mental health issues. She is also the founder of We Do Matter, which advocates more compassionate care for psychiatric patients and their families.
Dr. McIntosh’s new book, This is Depression: A comprehensive and compassionate guide for those who want to understand depression, was launched on October 10, 2019 and quickly became an Amazon Canada bestseller. It is written for those who have depression, for those who love someone who is depressed, and for anyone who wants to better understand the disorder.